12,356 XNAS Volume
XNAS 18 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Ronald T. Nixon | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 7,534 | 64,042 | - | 0 | Common Stock | |
| Michael D. McNeil | Ch. Acct. & Ch. Admin Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 5,037 | 31,035 | - | 0 | Common Stock | |
| Jacob A. Waldrop | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 8,790 | 11,891 | - | 0 | Common Stock | |
| Elizabeth B. Taylor | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 5,382 | 5,382 | - | 0 | Common Stock | |
| Keith G. Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2024 | 1,975 | 1,975 | - | 0 | Common Stock | |
| Eric D. Tanzberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 3,768 | 14,068 | - | 0 | Common Stock | |
| James W. Stuckert | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 3,440 | 840,218 | - | 0 | Common Stock | |
| Ronald T. Nixon | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 10,812 | 56,508 | - | 0 | Common Stock | |
| Eric D. Major | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 3,440 | 6,109 | - | 0 | Common Stock | |
| Sara N. Ortwein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 3,440 | 17,522 | - | 0 | Common Stock | |
| Robert Andrew DeSutter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 3,932 | 19,455 | - | 0 | Common Stock | |
| Ann Beal Salamone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 2,949 | 19,895 | - | 0 | Common Stock | |
| Roszell Mack | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 3,604 | 13,101 | - | 0 | Common Stock | |
| Jacob A. Waldrop | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 3,101 | 3,101 | - | 0 | Common Stock | |
| Zachary B. Fleming | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 12,693 | 48,854 | - | 0 | Common Stock | |
| Michael D. McNeil | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 4,650 | 25,998 | - | 0 | Common Stock | |
| Zachary B. Fleming | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.96 per share. | 01 Mar 2024 | 926 | 36,951 | - | 39.0 | 36,077 | Common Stock |
| Zachary B. Fleming | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.96 per share. | 01 Mar 2024 | 790 | 36,161 | - | 39.0 | 30,778 | Common Stock |
| Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.96 per share. | 01 Mar 2024 | 687 | 21,947 | - | 39.0 | 26,766 | Common Stock |
| Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.96 per share. | 01 Mar 2024 | 599 | 21,348 | - | 39.0 | 23,337 | Common Stock |
| Zachary Fleming B. | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.72 per share. | 01 Feb 2024 | 427 | 37,877 | - | 33.7 | 14,398 | Common Stock |
| Michael McNeil D. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.72 per share. | 01 Feb 2024 | 391 | 22,634 | - | 33.7 | 13,185 | Common Stock |
| Fleming Zachary B. | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.10 per share. | 01 Jan 2024 | 1,255 | 38,304 | - | 41.1 | 51,581 | Common Stock |
| Eric D. Tanzberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 2,936 | 10,300 | - | 0 | Common Stock | |
| James W. Stuckert | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 2,802 | 836,778 | - | 0 | Common Stock | |
| Ronald T. Nixon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 8,808 | 45,696 | - | 0 | Common Stock | |
| Ronald T. Nixon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 9,609 | 36,888 | - | 0 | Common Stock | |
| Eric D. Major | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 2,669 | 2,669 | - | 0 | Common Stock | |
| Sara N. Ortwein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 2,802 | 14,082 | - | 0 | Common Stock | |
| Robert Andrew DeSutter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 2,936 | 15,523 | - | 0 | Common Stock | |
| Ann Beal Salamone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 2,402 | 16,946 | - | 0 | Common Stock | |
| Roszell Mack | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 2,802 | 9,497 | - | 0 | Common Stock | |
| Michael D. McNeil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.00 per share. | 12 Apr 2023 | 1,000 | 23,025 | - | 6 | 6,000 | Common Stock |
| Michael D. McNeil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2023 | 1,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Zachary B. Fleming | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.50 per share. | 17 Mar 2023 | 1,101 | 42,097 | - | 40.5 | 44,591 | Common Stock |
| Zachary B. Fleming | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.50 per share. | 17 Mar 2023 | 717 | 40,243 | - | 41.5 | 29,756 | Common Stock |
| Zachary B. Fleming | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.30 per share. | 17 Mar 2023 | 325 | 40,960 | - | 43.3 | 14,073 | Common Stock |
| Zachary B. Fleming | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.50 per share. | 17 Mar 2023 | 812 | 41,285 | - | 40.5 | 32,886 | Common Stock |
| Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.50 per share. | 17 Mar 2023 | 532 | 22,025 | - | 41.5 | 22,078 | Common Stock |
| Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.30 per share. | 17 Mar 2023 | 253 | 22,557 | - | 43.3 | 10,955 | Common Stock |
| Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.50 per share. | 17 Mar 2023 | 658 | 22,810 | - | 40.5 | 26,649 | Common Stock |
| Rebecca E. McMahon | President - R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.50 per share. | 17 Mar 2023 | 201 | 9,595 | - | 41.5 | 8,342 | Common Stock |
| Zachary B. Fleming | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 1,736 | 43,198 | - | 0 | Common Stock | |
| Zachary B. Fleming | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 6,988 | 41,462 | - | 0 | Common Stock | |
| Michael D. McNeil | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 4,217 | 23,468 | - | 0 | Common Stock | |
| Rebecca E. McMahon | President - R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 2,410 | 9,796 | - | 0 | Common Stock | |
| Zachary B. Fleming | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.97 per share. | 02 Dec 2022 | 325 | 34,474 | - | 23.0 | 7,465 | Common Stock |
| Zachary B. Fleming | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.79 per share. | 02 Dec 2022 | 1,471 | 34,799 | - | 30.8 | 45,292 | Common Stock |
| Shawn M. Bowman | Pres. - Strat. Partnerships | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.97 per share. | 02 Dec 2022 | 260 | 15,883 | - | 23.0 | 5,972 | Common Stock |
| Shawn M. Bowman | Pres. - Strat. Partnerships | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.79 per share. | 02 Dec 2022 | 82 | 16,143 | - | 30.8 | 2,525 | Common Stock |
| Shawn M. Bowman | Pres. - Strat. Partnerships | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.86 per share. | 02 Dec 2022 | 1,101 | 16,225 | - | 36.9 | 40,583 | Common Stock |
| Shawn M. Bowman | Pres. - Strat. Partnerships | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.79 per share. | 02 Dec 2022 | 1,224 | 17,326 | - | 30.8 | 37,687 | Common Stock |
| Shawn M. Bowman | Pres. - Strat. Partnerships | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Dec 2022 | 4,414 | 11,469 | - | 0 | Common Stock | |
| Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.97 per share. | 02 Dec 2022 | 253 | 19,251 | - | 23.0 | 5,811 | Common Stock |
| Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.79 per share. | 02 Dec 2022 | 865 | 19,504 | - | 30.8 | 26,633 | Common Stock |
| Zachary B. Fleming | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 33.00 per share. | 08 Nov 2022 | 417 | 36,270 | - | 33 | 13,761 | Common Stock |
| Zachary B. Fleming | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 33.00 per share. | 04 Nov 2022 | 563 | 36,687 | - | 33 | 18,579 | Common Stock |
| Zachary B. Fleming | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 33.00 per share. | 02 Nov 2022 | 20 | 37,250 | - | 33 | 660 | Common Stock |
| Shawn M. Bowman | Pres. - Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 27.54 per share. | 22 Sep 2022 | 660 | 18,890 | - | 27.5 | 18,176 | Common Stock |
| Shawn M. Bowman | Pres. - Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 28.56 per share. | 22 Sep 2022 | 340 | 18,550 | - | 28.6 | 9,710 | Common Stock |
| Eric D. Tanzberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 5,027 | 7,364 | - | 0 | Common Stock | |
| James W. Stuckert | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 4,799 | 833,976 | - | 0 | Common Stock | |
| Ronald T. Nixon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 4,113 | 27,279 | - | 0 | Common Stock | |
| Kenneth E. Thorpe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 5,027 | 16,945 | - | 0 | Common Stock | |
| Sara N. Ortwein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 4,799 | 11,280 | - | 0 | Common Stock | |
| Robert Andrew DeSutter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 5,256 | 12,587 | - | 0 | Common Stock | |
| Ann Beal Salamone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 4,113 | 14,544 | - | 0 | Common Stock | |
| Roszell Mack | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 4,570 | 6,695 | - | 0 | Common Stock | |
| Zachary B. Fleming | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 21.45 per share. | 05 Jul 2022 | 265 | 38,685 | - | 21.4 | 5,684 | Common Stock |
| Zachary B. Fleming | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 05 Jul 2022 | 750 | 37,270 | - | 23 | 17,250 | Common Stock |
| Zachary B. Fleming | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 05 Jul 2022 | 665 | 38,020 | - | 22 | 14,630 | Common Stock |
| Zachary B. Fleming | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 21.00 per share. | 28 Jun 2022 | 294 | 38,950 | - | 21 | 6,174 | Common Stock |
| Zachary B. Fleming | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 21.00 per share. | 28 Jun 2022 | 69 | 39,244 | - | 21 | 1,449 | Common Stock |
| Zachary B. Fleming | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 21.00 per share. | 24 Jun 2022 | 457 | 39,313 | - | 21 | 9,597 | Common Stock |
| Shawn M. Bowman | Pres. - Strategic Partnerships | Sale of securities on an exchange or to another person at price $ 20.02 per share. | 17 Jun 2022 | 1,000 | 19,550 | - | 20.0 | 20,020 | Common Stock |
| Zachary B. Fleming | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 8,831 | 39,770 | - | 0 | Common Stock | |
| Shawn M. Bowman | President - Wound Care Div. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 2,284 | 20,550 | - | 0 | Common Stock | |
| Michael D. McNeil | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 6,547 | 20,369 | - | 0 | Common Stock | |
| Rebecca E. McMahon | President - R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 2,047 | 7,386 | - | 0 | Common Stock | |
| Eric D. Tanzberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 2,337 | 2,337 | - | 0 | Common Stock | |
| James W. Stuckert | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 4,887 | 826,946 | - | 0 | Common Stock | |
| James W. Stuckert | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 2,231 | 829,177 | - | 0 | Common Stock | |
| Ronald T. Nixon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 10,200 | 17,429 | - | 0 | Common Stock | |
| Ronald T. Nixon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 3,825 | 21,254 | - | 0 | Common Stock | |
| Ronald T. Nixon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 1,912 | 23,166 | - | 0 | Common Stock | |
| Kenneth E. Thorpe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 2,337 | 11,918 | - | 0 | Common Stock | |
| Kenneth E. Thorpe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 4,887 | 9,581 | - | 0 | Common Stock | |
| Kenneth E. Thorpe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 2,284 | 4,694 | - | 0 | Common Stock | |
| Sara N. Ortwein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 2,231 | 6,481 | - | 0 | Common Stock | |
| Sara N. Ortwein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 4,250 | 4,250 | - | 0 | Common Stock | |
| Robert Andrew DeSutter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 2,444 | 7,331 | - | 0 | Common Stock | |
| Robert Andrew DeSutter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 4,887 | 4,887 | - | 0 | Common Stock | |
| Ann Beal Salamone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 3,825 | 8,519 | - | 0 | Common Stock | |
| Ann Beal Salamone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 2,284 | 4,694 | - | 0 | Common Stock | |
| Ann Beal Salamone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 1,912 | 10,431 | - | 0 | Common Stock | |
| Roszell Mack | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 2,125 | 2,125 | - | 0 | Common Stock | |
| Zachary B. Fleming | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 10,000 | 30,939 | - | 0 | Common Stock | |
| Christopher A. Morrison | President - Telehealth Svcs. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 7,135 | 28,032 | - | 0 | Common Stock | |
| Zachary B. Fleming | President - Surgical Div. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 3,993 | 20,939 | - | 0 | Common Stock | |
| Shawn M. Bowman | President - Wound Care Div. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 3,195 | 18,226 | - | 0 | Common Stock | |
| J. Michael Carmena | Director, Principal Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 3,549 | 22,113 | - | 0 | Common Stock | |
| Michael D. McNeil | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 3,106 | 13,822 | - | 0 | Common Stock | |
| Zachary B. Fleming | President - Surgical Div. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.67 per share. | 16 Dec 2021 | 370 | 17,338 | - | 45.7 | 16,898 | Common Stock |
| Zachary B. Fleming | President - Surgical Div. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.53 per share. | 16 Dec 2021 | 196 | 16,946 | - | 35.5 | 6,964 | Common Stock |
| Zachary B. Fleming | President - Surgical Div. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.67 per share. | 16 Dec 2021 | 196 | 17,142 | - | 45.7 | 8,951 | Common Stock |
| Shawn M. Bowman | President - Wound Care Div. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.53 per share. | 16 Dec 2021 | 196 | 15,071 | - | 35.5 | 6,964 | Common Stock |
| Shawn M. Bowman | President - Wound Care Div. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.67 per share. | 16 Dec 2021 | 123 | 15,545 | - | 45.7 | 5,617 | Common Stock |
| Shawn M. Bowman | President - Wound Care Div. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.67 per share. | 16 Dec 2021 | 82 | 15,463 | - | 45.7 | 3,745 | Common Stock |
| Shawn M. Bowman | President - Wound Care Div. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.67 per share. | 16 Dec 2021 | 196 | 15,267 | - | 45.7 | 8,951 | Common Stock |
| Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.67 per share. | 16 Dec 2021 | 864 | 11,020 | - | 45.7 | 39,459 | Common Stock |
| Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.67 per share. | 16 Dec 2021 | 152 | 10,868 | - | 45.7 | 6,942 | Common Stock |
| Michael D. McNeil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.53 per share. | 16 Dec 2021 | 152 | 10,716 | - | 35.5 | 5,401 | Common Stock |
| Zachary B. Fleming | President - Surgical Div. | Sale of securities on an exchange or to another person at price $ 34.04 per share. | 26 Oct 2021 | 1,000 | 17,708 | - | 34.0 | 34,040 | Common Stock |
| Shawn M. Bowman | President - Wound Care Div. | Sale of securities on an exchange or to another person at price $ 33.47 per share. | 20 Oct 2021 | 300 | 16,368 | - | 33.5 | 10,041 | Common Stock |
| Shawn M. Bowman | President - Wound Care Div. | Sale of securities on an exchange or to another person at price $ 34.50 per share. | 20 Oct 2021 | 700 | 15,668 | - | 34.5 | 24,150 | Common Stock |
| Zachary B. Fleming | President - Surgical Div. | Sale of securities on an exchange or to another person at price $ 32.76 per share. | 05 Oct 2021 | 471 | 19,237 | - | 32.8 | 15,430 | Common Stock |
| Zachary B. Fleming | President - Surgical Div. | Sale of securities on an exchange or to another person at price $ 33.41 per share. | 05 Oct 2021 | 529 | 18,708 | - | 33.4 | 17,674 | Common Stock |
| Shawn M. Bowman | President - Wound Care Div. | Sale of securities on an exchange or to another person at price $ 33.33 per share. | 28 Sep 2021 | 1,000 | 16,668 | - | 33.3 | 33,330 | Common Stock |
| Rebecca E. McMahon | President of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2021 | 5,339 | 5,339 | - | 0 | Common Stock | |
| Zachary B. Fleming | President - Surgical Div. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 1,603 | 19,708 | - | 0 | Common Stock | |
| Shawn M. Bowman | President - Wound Care Div. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 1,603 | 18,668 | - | 0 | Common Stock | |
| J. Michael Carmena | Director, Principal Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 1,425 | 18,674 | - | 0 | Common Stock | |
| J. Michael Carmena | Director, Principal Executive Officer | Grant, award, or other acquisition of securities at price $ 10.53 per share. | 30 Sep 2020 | 1,092 | 19,766 | - | 10.5 | 11,499 | Common Stock |
| Michael D. McNeil | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 1,247 | 11,884 | - | 0 | Common Stock | |
| Araldo A. Cossutta | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Dec 2007 | 15,000 | 5,015,000 | - | - | Common Stock | |
| Araldo A. Cossutta | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Aug 2004 | 3,025,900 | 4,750,900 | - | - | Common Stock | |
| Scott A. Haire | Director, President & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Aug 2004 | 4,646,403 | 4,646,403 | - | - | Common Stock | |
| Scott A. Haire | Director, President & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Nov 2003 | 1,971,667 | 2,238,880 | - | - | Common Stock | |
| Araldo A. Cossutta | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Nov 2003 | 1,695,000 | 1,725,000 | - | - | Common Stock | |
| Steven W. Evans | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Nov 2003 | 1,333,333 | 1,348,333 | - | - | Common Stock |